Glenmede Trust CO Na Merck & Co., Inc. Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Merck & Co., Inc. stock. As of the latest transaction made, Glenmede Trust CO Na holds 1,098,241 shares of MRK stock, worth $108 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

1,098,241

Previous 682,901 60.82%

Holding current value

$108 Million

Previous $84.5 Million 47.52%

% of portfolio

0.6%

Previous 0.43%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$111.15 - $128.97 $46.2 Million - $53.6 Million	415,340 Added 60.82%	1,098,241 $125 Million
Q2 2024 Aug 14, 2024	SELL	$123.8 - $132.96 $1.02 Million - $1.1 Million	-8,274 Reduced 1.2%	682,901 $84.5 Million
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $2.28 Million - $2.65 Million	-20,115 Reduced 2.83%	691,175 $91.2 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $24 Million - $26.2 Million	-239,929 Reduced 25.22%	711,290 $77.5 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $7.7 Million - $8.55 Million	-74,786 Reduced 7.29%	951,219 $97.9 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $32,800 - $35,750	-302 Reduced 0.03%	1,026,005 $118 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $12.6 Million - $14.1 Million	122,755 Added 13.59%	1,026,307 $109 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $3.39 Million - $4.35 Million	-38,783 Reduced 4.12%	903,552 $100 Million
Q3 2022 Nov 16, 2022	BUY	$84.53 - $94.96 $10.5 Million - $11.8 Million	123,882 Added 15.14%	942,335 $81.2 Million
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $1.29 Million - $1.47 Million	15,501 Added 1.93%	818,453 $74.6 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $3.86 Million - $4.32 Million	-52,482 Reduced 6.14%	802,952 $65.9 Million
Q4 2021 Feb 15, 2022	BUY	$72.28 - $90.54 $2.35 Million - $2.95 Million	32,545 Added 3.95%	855,434 $65.6 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $577,525 - $635,133	8,057 Added 0.99%	822,889 $61.8 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $22.5 Million - $24.9 Million	-320,527 Reduced 28.23%	814,832 $63.4 Million
Q1 2021 May 18, 2021	SELL	$68.86 - $81.11 $12.9 Million - $15.2 Million	-187,105 Reduced 14.15%	1,135,359 $87.5 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $6.25 Million - $6.93 Million	-87,043 Reduced 6.18%	1,322,464 $108 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $586,684 - $665,010	-8,017 Reduced 0.57%	1,409,507 $117 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $31.7 Million - $36 Million	-449,683 Reduced 24.08%	1,417,524 $110 Million
Q4 2019 Feb 12, 2020	SELL	$77.58 - $87.54 $15.8 Million - $17.8 Million	-203,697 Reduced 9.84%	1,867,207 $170 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $48 Million - $52.3 Million	630,336 Added 43.76%	2,070,904 $174 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $25.6 Million - $29.9 Million	366,025 Added 34.06%	1,440,568 $121 Million
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $698,026 - $796,139	10,032 Added 0.94%	1,074,543 $89.4 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $538,621 - $625,061	-8,256 Reduced 0.77%	1,064,511 $81.3 Million
Q3 2018 Nov 15, 2018	SELL	$57.69 - $67.84 $204,164 - $240,085	-3,539 Reduced 0.33%	1,072,767 $76.1 Million
Q2 2018 Nov 05, 2018	SELL	$50.83 - $59.72 $163 Million - $191 Million	-3,205,173 Reduced 74.86%	1,076,306 $65.3 Million
Q2 2018 Aug 15, 2018	BUY	$50.83 - $59.72 $105 Million - $124 Million	2,072,683 Added 93.84%	4,281,479 $260 Million
Q4 2017 Feb 15, 2018	SELL	$51.62 - $61.64 $23.3 Million - $27.9 Million	-451,903 Reduced 16.98%	2,208,796 $124 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $156 Million - $168 Million	2,660,699	2,660,699 $0

Others Institutions Holding MRK

# of Institutions

3,814

Shares Held

1.88B

Call Options Held

14.6M

Put Options Held

13.2M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Merck & Co., Inc. Transaction History